Market Cap

Antisense Therapeutics Limited Market Capitalization:

A$52.3 Million

AUD as of Jan. 1, 2024

US$35.6 Million

business Antisense Therapeutics Limited Company Profile

Antisense Therapeutics Limited Main Stock Listing

ASX: ANP

Market Capitalization History of Antisense Therapeutics Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Antisense Therapeutics Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$52.3 M -16.86%
Jan. 1, 2023 A$62.9 M -44.71%
Jan. 1, 2022 A$113.7 M -5.56%
Jan. 31, 2021 A$120.4 M 2.86%
Jan. 1, 2021 A$117.1 M 196.61%
Jan. 31, 2020 A$39.5 M -11.94%
Jan. 1, 2020 A$44.8 M 76.32%
Jan. 31, 2019 A$25.4 M -7.32%
Jan. 1, 2019 A$27.4 M 2.04%
Jan. 31, 2018 A$26.9 M -14.58%
Jan. 1, 2018 A$31.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Antisense Therapeutics Limited Categories

Australia languages Healthcare languages Drug Manufacturers—Specialty & Generic
Australia Healthcare Australia Drug Manufacturers—Specialty & Generic

Stocks & Indices

Antisense Therapeutics Limited has the following listings and related stock indices.


Stock: ASX: ANP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.